Company Analysis

Roivant Sciences Ltd. (ROIV)

Nasdaq: ROIV · Pharmaceutical Preparations · London · filing with the SEC since 2015
Grade5.3
◀ Past 6.1● Present 6.5▶ Future 3.6

Who runs Roivant Sciences Ltd.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Gline Matthew
CEO. First filing Oct 2021, latest Nov 12, 2026, 15 filings in all.
Officers reporting now
6
of 15 people with a filing in the last fifteen months
Directors reporting now
9
21 people on the record since 2021
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Gline MatthewCEOOct 2021Nov 12, 20264 · $46.2M
Venker EricPresident & Immunovant CEOOct 2021Nov 12, 202620 · $95.0M
Torti FrankPresident and Vant ChairJul 2025Nov 12, 20263 · $82.0M
Sukhatme MayukhPresident & CIOOct 2021Nov 12, 202613 · $109M
Pulik RichardCFOOct 2021Nov 12, 20266 · $21.6M
Humes JenniferChief Accounting OfficerFeb 2025Sep 22, 20261 · $400,000
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Epperly Melissa B,directorJul 2022Oct 27, 20267 · $2.6M
Momtazee James CdirectorOct 2021Oct 27, 2026none
Oren IlandirectorOct 2021Oct 27, 2026none
Roivant Sciences Ltd.directorOct 2026Oct 5, 2026none
Fitzgerald MeghandirectorMar 2023Sep 18, 20265 · $3.3M
Gold Daniel AllendirectorOct 2021Sep 18, 202619 · $147M
Manchester Keith SdirectorOct 2021Sep 18, 202620 · $155M
Qvt Financial LPdirectorOct 2021Jun 30, 202619 · $147M
Ramaswamy VivekdirectorOct 2021Dec 15, 20256 · $106M
Earlier names on the record26, newest filing first
Kumar Rakhi · officer · last filing Feb 2025Sb Investment Advisers (Uk) Ltd · 10% owner · last filing Oct 2023Softbank Vision Fund L.P. · 10% owner · last filing Oct 2023Svf Holdings (Uk) Llp · 10% owner · last filing Oct 2023Svf Investments (Uk) Ltd · 10% owner · last filing Oct 2023Halvorsen Ole Andreas · 10% owner · last filing Jun 2023Ott David C. · 10% owner · last filing Jun 2023Shabet Rose Sharon · 10% owner · last filing Jun 2023Sumitomo Chemical Co., Ltd. · 10% owner · last filing Jun 2023Sumitomo Pharma Co., Ltd. · 10% owner · last filing Jun 2023Viking Global Equities II LP · 10% owner · last filing Jun 2023Viking Global Equities Master Ltd. · 10% owner · last filing Jun 2023Viking Global Investors LP · 10% owner · last filing Jun 2023Viking Global Opportunities Gp LLC · 10% owner · last filing Jun 2023Viking Global Opportunities Illiquid Investments Sub-Master LP · 10% owner · last filing Jun 2023Viking Global Opportunities Parent Gp LLC · 10% owner · last filing Jun 2023Viking Global Opportunities Portfolio Gp LLC · 10% owner · last filing Jun 2023Viking Global Performance LLC · 10% owner · last filing Jun 2023Viking Long Fund Gp LLC · 10% owner · last filing Jun 2023Viking Long Fund Master Ltd. · 10% owner · last filing Jun 2023Dexcel Pharma Technologies Ltd. · 10% owner · last filing Nov 2022Nomura Hiroshi · director · last filing Sep 2022Lo Andrew · director · last filing Sep 2022Zimmer Benjamin · officer · last filing Oct 2021Machado Patrick · director · last filing Oct 2021Tada Masayo · director · last filing Oct 2021

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ROIV · research, not advice